Kuros Biosciences | Extremities
@kuros_extremities
Atlanta, Georgia Medical Equipment ManufacturingOverview
About Kuros Biosciences | Extremities
Kuros Extremities is a business unit within Kuros Biosciences specifically focused on developing research-backed osteobiologic solutions for the foot & ankle, trauma, and upper extremity segments.
OUR PURPOSE
Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies.
OUR CREDENTIALS
Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team.
To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing.
• Level 1 evidence published in Spine
• 20 well-controlled Level I – IV clinical trials initiated or completed to date
• >320 cumulative scientific papers, decades of research advancing bone graft innovation
• >25 orthobiologic patents secured
• >20 commercial markets serving spine, extremities, trauma and oncology
• 12 U.S. FDA clearances granted to date, 12 expanding MagnetOs indications
CONTACT KUROS TO FIND OUT MORE >>>>
OUR PURPOSE
Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies.
OUR CREDENTIALS
Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team.
To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing.
• Level 1 evidence published in Spine
• 20 well-controlled Level I – IV clinical trials initiated or completed to date
• >320 cumulative scientific papers, decades of research advancing bone graft innovation
• >25 orthobiologic patents secured
• >20 commercial markets serving spine, extremities, trauma and oncology
• 12 U.S. FDA clearances granted to date, 12 expanding MagnetOs indications
CONTACT KUROS TO FIND OUT MORE >>>>